ISDA

Deposition Date 2013-09-25

Release Date 2014-04-02

Last Version Date 2023-12-20

Entry Detail

PDB ID:

4C7T

Keywords:

TRANSFERASE

Title:

Focal Adhesion Kinase catalytic domain in complex with a diarylamino- 1,3,5-triazine inhibitor

Biological Source:

Source Organism:

GALLUS GALLUS (Taxon ID: 9031)

Host Organism:

TRICHOPLUSIA NI

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

2.05 Å

R-Value Free:

0.24

R-Value Work:

0.21

R-Value Observed:

0.22

Space Group:

P 1 21 1

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Molecule:FOCAL ADHESION KINASE 1
Gene (Uniprot):PTK2
Chain IDs:A
Chain Length:276
Number of Molecules:1
Biological Source:GALLUS GALLUS

UniProt ID:Q00944 Pfam ID:PF07714 EC:2.7.10.2

Primary Citation

Inhibition of Both Focal Adhesion Kinase and Fibroblast Growth Factor Receptor 2 Pathways Induces Anti-Tumor and Anti-Angiogenic Activities.

Dao, P, Jarray, R, Smith, N, Lepelletier, Y, Le Coq, J, Lietha, D, Hadj-Slimane, R, Herbeuval, J.P, Garbay, C, Raynaud, F, Chen, H.Show

Cancer Lett. 348 88 ? (2014)

PMID: 24657306 DOI: 10.1016/J.CANLET.2014.03.007

Abstact

FAK and FGFR2 signaling pathways play important roles in cancer development, progression and tumor angiogenesis. PHM16 is a novel ATP competitive inhibitor of FAK and FGFR2. To evaluate the therapeutic efficacy of this agent, we examined its anti-angiogenic effect in HUVEC and its anti-tumor effect in different cancer cell lines. We showed PHM16 inhibited endothelial cell viability, adherence and tube formation along with the added ability to induce endothelial cell apoptosis. This compound significantly delayed tumor cell growth. Together, these data showed that inhibition of both FAK and FGFR2 signaling pathways can enhance anti-tumor and anti-angiogenic activities.

Legend

Protein

Chemical

Disease

Primary Citation of related structures